Access cutting-edge hepatocellular carcinoma (hcc) treatment through this clinical trial at a research site in Lebanon. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Lebanon location
Preparing your pre-screening questions…
Access hepatocellular carcinoma (hcc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatocellular carcinoma (hcc) treatment provided free
Check if you qualify for this hepatocellular carcinoma (hcc) clinical trial in Lebanon, NH
No-Cost Study Care
Local to Lebanon
Convenient for NH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to learn if the intraoperative use of a computer guidance software can improve the success of liver tumor ablation in adults. The employed software calculates and displays a simulation of the ablation such that the physician can visualize what portion of the target tumor has, and has not been treated at any point during the procedure. The main questions it aims to answer are: 1) Does the use of the computer guidance software reduce the number of times a tumor is incompletely treated. 2) Does the use of the computer guidance software reduce the rate of local tumor recurrence at 2 year follow-up? 3) Was there an increase or a decrease in medical problems for participants after a procedure where the guidance software was used? Researchers will compare liver tumor treatment using the computer guidance software with an historic control to see if the addition of the guidance software improved the outcomes after an ablation. Participants will: Undergo CT-guided microwave ablation treatment of a liver tumor using computer-assisted simulation. Visit the clinic at one month and then every 3 months for blood tests and a contrast-enhanced CT or MRI imaging study (as per standard of care)
Sponsor: NE Scientific INC
Yes, this clinical trial (NCT07226869) has an active research site in Lebanon, NH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hepatocellular carcinoma (hcc) treatment options in Lebanon, NH, this clinical trial (NCT07226869) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lebanon research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatocellular carcinoma (hcc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hepatocellular carcinoma (hcc) clinical trials near you to find additional studies recruiting in your area.
See all liver cancer clinical trials recruiting in Lebanon — not just this study.
Browse Liver Cancer Trials in Lebanon →